GT Biopharma Cash from Financing (TTM) Analysis

GT Biopharma Inc (GTBP)

3.21 -0.09 (-2.73%) USD | NASDAQ | May 06, 16:00

3.21 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 1992. Upgrade now.

Date	Value
December 31, 2023	6.268M
September 30, 2023	6.267M
June 30, 2023	6.267M
March 31, 2023	6.044M
December 31, 2022	-0.224M
September 30, 2022	-0.223M
June 30, 2022	-0.086M
March 31, 2022	16.38M
December 31, 2021	42.32M
September 30, 2021	49.19M
June 30, 2021	50.25M
March 31, 2021	38.27M
December 31, 2020	12.53M
September 30, 2020	5.857M
June 30, 2020	5.632M
March 31, 2020	2.675M
December 31, 2019	3.427M
September 30, 2019	3.331M
June 30, 2019	5.927M
March 31, 2019	4.627M
December 31, 2018	10.20M
September 30, 2018	10.09M
June 30, 2018	11.45M
March 31, 2018	11.65M
December 31, 2017	5.991M

Date	Value
September 30, 2017	5.991M
June 30, 2017	1.423M
March 31, 2017	2.618M
December 31, 2016	1.902M
September 30, 2016	2.852M
June 30, 2016	3.04M
March 31, 2016	1.65M
December 31, 2015	3.85M
September 30, 2015	4.154M
June 30, 2015	4.844M
March 31, 2015	4.883M
December 31, 2014	2.583M
September 30, 2014	1.753M
June 30, 2014	0.513M
March 31, 2014	0.474M
December 31, 2013	0.425M
September 30, 2013	0.316M
June 30, 2013	0.523M
March 31, 2013	0.711M
December 31, 2012	0.93M
September 30, 2012	1.031M
June 30, 2012	0.834M
March 31, 2012	1.127M
December 31, 2011	1.001M
September 30, 2011	0.835M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.224M

Minimum

Dec 2022

50.25M

Maximum

Jun 2021

13.69M

Average

6.044M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks